Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 86Lung Neoplasms 32Small Cell Lung Carcinoma 18Melanoma 17Mesothelioma 13Neoplasms 11Colorectal Neoplasms 9Carcinoma, Renal Cell 9Squamous Cell Carcinoma of Head and Neck 7Neoplasm Metastasis 7Mesothelioma, Malignant 7Carcinoma, Transitional Cell 7Ovarian Neoplasms 6Diabetes Mellitus, Insulin-Dependent, 12 6Urinary Bladder Neoplasms 5Triple Negative Breast Neoplasms 5Pancreatic Neoplasms 5Liver Neoplasms 5Endometrial Neoplasms 5Carcinoma, Hepatocellular 5Uterine Cervical Neoplasms 4Stomach Neoplasms 4Kidney Neoplasms 4Brain Neoplasms 4Carcinoma, Merkel Cell 3Skin Neoplasms 2Sarcoma 2Prostatic Neoplasms 2Lung Diseases 2Head and Neck Neoplasms 2

Interventions

Specimen Handling 3Magnetic Resonance Spectroscopy 3Nivolumab 2Biopsy 2pembrolizumab 1cabozantinib 1Vorinostat 1Tomography, X-Ray Computed 1Taxes 1Spirometry 1Paclitaxel 1Ipilimumab 1Gene Expression Profiling 1Flow Cytometry 1Erlotinib Hydrochloride 1Carboplatin 1CTLA-4 Antigen 1Antiretroviral Therapy, Highly Active 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
HIV Infections × Ipilimumab × Thoracic × Clear all
NCT02408861 2026-01-21

Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 1 Terminated
79 enrolled 24 charts
GastrointestinalSarcomaThoracic

Anus Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡